サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：超大容量ウェアラブルインジェクターの世界市場：適応症別（糖尿病、自己免疫疾患、腫瘍、その他） - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
市場調査レポート
商品コード
1110446

超大容量ウェアラブルインジェクターの世界市場：適応症別（糖尿病、自己免疫疾患、腫瘍、その他） - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Ultra-large Volume Wearable Injectors Market (Indication: Diabetes, Autoimmune Diseases, Oncology, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 144 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
超大容量ウェアラブルインジェクターの世界市場：適応症別（糖尿病、自己免疫疾患、腫瘍、その他） - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年06月07日
発行: Transparency Market Research
ページ情報: 英文 144 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の超大容量ウェアラブルインジェクター市場について調査し、市場規模や予測、市場力学、セグメント・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界の超大容量ウェアラブルインジェクター市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の超大容量ウェアラブルインジェクター市場分析と予測（2017年～2031年）
    • 市場収益予測（金額）

第5章 重要な洞察

  • パイプライン分析
  • 主な業界の発展
  • 超大容量ウェアラブルインジェクターの概要
  • COVID-19パンデミックが業界に与える影響

第6章 世界の超大容量ウェアラブルインジェクター市場分析と予測：適応症別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場予測（金額）：適応症別（2017年～2031年）
    • 糖尿病
    • 自己免疫疾患
    • 腫瘍
    • その他
  • 市場の魅力：適応症別

第7章 世界の超大容量ウェアラブルインジェクター市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場予測（金額）：流通チャネル別（2017年～2031年）
    • 小売薬局とドラッグストア
    • eコマース
    • その他
  • 市場の魅力：流通チャネル別

第8章 世界の超大容量ウェアラブルインジェクター市場分析と予測：地域別

  • 主な調査結果
  • 市場予測（金額）：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：流通チャネル別

第9章 北米の超大容量ウェアラブルインジェクター市場分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場予測（金額）：適応症別（2017年～2031年）
  • 市場予測（金額）：流通チャネル別（2017年～2031年）
  • 市場予測（金額）：国別（2017年～2031年）
    • 米国
    • カナダ
  • 市場魅力分析

第10章 欧州の超大容量ウェアラブルインジェクター市場分析と予測

第11章 アジア太平洋の超大容量ウェアラブルインジェクター市場分析と予測

第12章 ラテンアメリカの超大容量ウェアラブルインジェクター市場分析と予測

第13章 中東・アフリカの超大容量ウェアラブルインジェクター市場分析と予測

第14章 競合情勢

  • 市場企業 - 競合マトリクス（企業の階層およびティア別）
  • 企業プロファイル
    • Becton, Dickinson and Company
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Buhler Motor GmbH
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • West Pharmaceutical Services, Inc.
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Ypsomed AG
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Medtronic
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Sonceboz
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Enable Injections
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Subcuject Aps
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Nemera
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Eitan Medical
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Weibel CDS AG
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
    • Gerresheimer AG
      • 企業概要
      • 財務概要
      • 製品ポートフォリオ
      • SWOT分析
      • 戦略概要
図表

List of Tables

  • Table 01: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
  • Table 02: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 03: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Region, 2017-2031
  • Table 04: North America Continence Care Market Value (US$ Bn) Forecast, by Country, 2017-2031
  • Table 05: North America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
  • Table 06: North America Ultra-large Volume Wearable Injectors Market (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 07: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 08: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
  • Table 09: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 10: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 11: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
  • Table 12: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 14: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
  • Table 15: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 17: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017-2031
  • Table 18: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 02: Global Ultra-large Volume Wearable Injectors Market Value Share, by Indication, 2021
  • Figure 03: Global Ultra-large Volume Wearable Injectors Market Value Share, by Distribution Channel, 2021
  • Figure 04: Global Ultra-large Volume Wearable Injectors Market Value Share, by Region, 2021
  • Figure 05: Global Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
  • Figure 06: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2021-2031
  • Figure 07: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Diabetes, 2017-2031
  • Figure 08: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Autoimmune Diseases, 2017-2031
  • Figure 09: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Oncology, 2017-2031
  • Figure 10: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Others, 2017-2031
  • Figure 11: Global Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
  • Figure 12: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 13: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Retail Pharmacies & Drug stores, 2017-2031
  • Figure 14: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by E-commerce, 2017-2031
  • Figure 15: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Others, 2017-2031
  • Figure 16: Global Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 17: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 19: North America Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 20: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 21: North America Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031
  • Figure 22: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 23: North America Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031
  • Figure 24: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2021-2031
  • Figure 25: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 26: Europe Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
  • Figure 27: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 28: Europe Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031
  • Figure 29: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 30: Europe Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
  • Figure 31: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 32: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 33: Asia Pacific Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
  • Figure 34: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 35: Asia Pacific Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
  • Figure 36: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 37: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 38: Asia Pacific Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
  • Figure 39: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 40: Latin America Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
  • Figure 41: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Latin America Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
  • Figure 43: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 44: Latin America Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
  • Figure 45: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 46: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 47: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
  • Figure 48: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 49: Middle East & Africa Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031
  • Figure 50: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 51: Middle East & Africa Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031
  • Figure 52: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022-2031
目次
Product Code: TMRGL78474

The report provides revenue of the global ultra-large volume wearable injectors market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ultra-large volume wearable injectors market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ultra-large volume wearable injectors market.

The report delves into the competitive landscape of the global ultra-large volume wearable injectors market. Key players operating in the global ultra-large volume wearable injectors market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global ultra-large volume wearable injectors market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Ultra-large Volume Wearable Injectors Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Indication Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Industry Developments
  • 5.3. Ultra-large Volume Wearable Injectors Overview
  • 5.4. COVID-19 Pandemics Impact on Industry

6. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Indication

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Indication, 2017-2031
    • 6.3.1. Diabetes
    • 6.3.2. Autoimmune Diseases
    • 6.3.3. Oncology
    • 6.3.4. Others
  • 6.4. Market Attractiveness, by Indication

7. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 7.3.1. Retail Pharmacies & Drug stores
    • 7.3.2. E-commerce
    • 7.3.3. Others
  • 7.4. Market Attractiveness, by Distribution Channel

8. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness, by Region

9. North America Ultra-large Volume Wearable Injectors Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Indication, 2017-2031
    • 9.2.1. Diabetes
    • 9.2.2. Autoimmune Diseases
    • 9.2.3. Oncology
    • 9.2.4. Others
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Retail Pharmacies & Drug stores
    • 9.3.2. E-commerce
    • 9.3.3. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Indication
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Ultra-large Volume Wearable Injectors Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Indication, 2017-2031
    • 10.2.1. Diabetes
    • 10.2.2. Autoimmune Diseases
    • 10.2.3. Oncology
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Retail Pharmacies & Drug stores
    • 10.3.2. E-commerce
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Indication
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Ultra-large Volume Wearable Injectors Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Indication, 2017-2031
    • 11.2.1. Diabetes
    • 11.2.2. Autoimmune Diseases
    • 11.2.3. Oncology
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.3.1. Retail Pharmacies & Drug stores
    • 11.3.2. E-commerce
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Indication
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Ultra-large Volume Wearable Injectors Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Indication, 2017-2031
    • 12.2.1. Diabetes
    • 12.2.2. Autoimmune Diseases
    • 12.2.3. Oncology
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.3.1. Retail Pharmacies & Drug stores
    • 12.3.2. E-commerce
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Indication
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Ultra-large Volume Wearable Injectors Market Analysis and Forecast

. Introduction

    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Indication, 2017-2031
    • 13.2.1. Diabetes
    • 13.2.2. Autoimmune Diseases
    • 13.2.3. Oncology
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.3.1. Retail Pharmacies & Drug stores
    • 13.3.2. E-commerce
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Indication
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Company Profiles
    • 14.2.1. Becton, Dickinson and Company
      • 14.2.1.1. Company Overview
      • 14.2.1.2. Financial Overview
      • 14.2.1.3. Product Portfolio
      • 14.2.1.4. SWOT Analysis
      • 14.2.1.5. Strategic Overview
    • 14.2.2. Buhler Motor GmbH
      • 14.2.2.1. Company Overview
      • 14.2.2.2. Financial Overview
      • 14.2.2.3. Product Portfolio
      • 14.2.2.4. SWOT Analysis
      • 14.2.2.5. Strategic Overview
    • 14.2.3. West Pharmaceutical Services, Inc.
      • 14.2.3.1. Company Overview
      • 14.2.3.2. Financial Overview
      • 14.2.3.3. Product Portfolio
      • 14.2.3.4. SWOT Analysis
      • 14.2.3.5. Strategic Overview
    • 14.2.4. Ypsomed AG
      • 14.2.4.1. Company Overview
      • 14.2.4.2. Financial Overview
      • 14.2.4.3. Product Portfolio
      • 14.2.4.4. SWOT Analysis
      • 14.2.4.5. Strategic Overview
    • 14.2.5. Medtronic
      • 14.2.5.1. Company Overview
      • 14.2.5.2. Financial Overview
      • 14.2.5.3. Product Portfolio
      • 14.2.5.4. SWOT Analysis
      • 14.2.5.5. Strategic Overview
    • 14.2.6. Sonceboz
      • 14.2.6.1. Company Overview
      • 14.2.6.2. Financial Overview
      • 14.2.6.3. Product Portfolio
      • 14.2.6.4. SWOT Analysis
      • 14.2.6.5. Strategic Overview
    • 14.2.7. Enable Injections
      • 14.2.7.1. Company Overview
      • 14.2.7.2. Financial Overview
      • 14.2.7.3. Product Portfolio
      • 14.2.7.4. SWOT Analysis
      • 14.2.7.5. Strategic Overview
    • 14.2.8. Subcuject Aps
      • 14.2.8.1. Company Overview
      • 14.2.8.2. Financial Overview
      • 14.2.8.3. Product Portfolio
      • 14.2.8.4. SWOT Analysis
      • 14.2.8.5. Strategic Overview
    • 14.2.9. Nemera
      • 14.2.9.1. Company Overview
      • 14.2.9.2. Financial Overview
      • 14.2.9.3. Product Portfolio
      • 14.2.9.4. SWOT Analysis
      • 14.2.9.5. Strategic Overview
    • 14.2.10. Eitan Medical
      • 14.2.10.1. Company Overview
      • 14.2.10.2. Financial Overview
      • 14.2.10.3. Product Portfolio
      • 14.2.10.4. SWOT Analysis
      • 14.2.10.5. Strategic Overview
    • 14.2.11. Weibel CDS AG
      • 14.2.11.1. Company Overview
      • 14.2.11.2. Financial Overview
      • 14.2.11.3. Product Portfolio
      • 14.2.11.4. SWOT Analysis
      • 14.2.11.5. Strategic Overview
    • 14.2.12. Gerresheimer AG
      • 14.2.12.1. Company Overview
      • 14.2.12.2. Financial Overview
      • 14.2.12.3. Product Portfolio
      • 14.2.12.4. SWOT Analysis
      • 14.2.12.5. Strategic Overview